New Gene-Targeting shot shows promise for cholesterol control
Disease control
Completed
This early-stage study tested a single injection of EDP167, a new drug that uses RNA technology to lower certain blood fats. The study included 40 healthy adults and people with mild dyslipidemia (abnormal cholesterol levels). The main goal was to check the drug's safety and how …
Phase: PHASE1 • Sponsor: Eddingpharm (Zhuhai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC